Keeping your options open is becoming the thing to do in biotech.
Many boards of private drug developers are electing to simultaneously seek an IPO …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week
Study explores the differential effects of short and long-duration space missions on muscle protein nitrosylation in astronauts, indicating adaptations and potential impairments in muscle function
A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the